Blade Therapeutics is a therapeutics company with a mission to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Blade’s leadership team has extensive experience at developing drugs that treat fibrotic disorders. Blade is also partnering with international experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.